shortagewatch

Home / Genito-urinary system and sex hormones / Dinoprostone

ATC G02AD02 · Other Gynecologicals

Dinoprostone shortage

As of 31 Oct 2026, Dinoprostone has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Austria, Belgium), covering 9 products.

Countries4/5
Products9packs or presentations
Short since21 Jul 202515 months ago
Earliest return31 Oct 2026company estimate
No return date1products
Main reasonManufacturing problem
Germany4 packs shortItaly2 packs shortSpainNo reported shortageAustria1 pack shortBelgium2 packs short

Timeline

GermanyItalyAustriaBelgium
20262027Minprostin E2 VaginaltablettenMinprostin E2 VaginaltablettenMinprostin E2 Vaginalgel 1mgMinprostin E2 Vaginalgel 1mgMinprostin E2 Vaginalgel 2mgMinprostin E2 Vaginalgel 2mgPrepidil GelPrepidil GelPREPIDILPREPIDILPREPIDILPREPIDILProstin E2 3 mg - Vaginaltabletten, 4 StückProstin E2 3 mg - Vaginaltabletten, 4 StückProstin E2 3 mg vagin. tabl. 4Prostin E2 3 mg vagin. tabl. 4Prostin E2 0.5 mg tabl. 10Prostin E2 0.5 mg tabl. 10today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEMinprostin E2 VaginaltablettenPfizer Pharma GmbH21 Jul 202528 Feb 2027Manufacturing problem
Produktionsproblem
DEMinprostin E2 Vaginalgel 1mgPfizer Pharma GmbH1 Dec 202531 Oct 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEMinprostin E2 Vaginalgel 2mgPfizer Pharma GmbH1 Dec 202530 Nov 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEPrepidil GelPfizer Pharma GmbH23 Jan 202628 Feb 2027Increased demand
Erhöhte Nachfrage
ITPREPIDILPFIZER ITALIA S.R.L.6 Oct 202530 Dec 2026Manufacturing problem
Problemi produttivi
ITPREPIDILPFIZER ITALIA S.R.L.22 Dec 202530 Nov 2026Manufacturing problem
Problemi produttivi
ATProstin E2 3 mg - Vaginaltabletten, 4 StückPfizer Corporation Austria Ges.m.b.H.30 Jul 2025not givenManufacturing problem
Verzögerung bei der Herstellung
BEProstin E2 3 mg vagin. tabl. 4Pfizer12 Nov 202512 Feb 2027Active ingredient shortage
Excipient not available
BEProstin E2 0.5 mg tabl. 10Pfizer5 Dec 202515 Jan 2027Active ingredient shortage
Active Substance not available

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.